Circulating MicroRNA in inflammatory bowel disease

Journal of Crohn's and Colitis

Volumn 6, Issue 9, 2012, Pages 900-904

  Paraskevi, Archanioti ^a   Theodoropoulos, George ^b   Papaconstantinou, Ioannis ^c   Mantzaris, Gerassimos ^d   Nikiteas, Nikolaos ^a   Gazouli, Maria ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HIPPOKRATION HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

^d EVANGELISMOS HOSPITAL   (Greece)

Author keywords

IBD; Inflammation; MiRNAs

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 106A; MICRORNA 107; MICRORNA 16; MICRORNA 191; MICRORNA 199A; MICRORNA 200C; MICRORNA 23A; MICRORNA 29A; MICRORNA 362; MICRORNA 532; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CROHN DISEASE; DISEASE CLASSIFICATION; ENTERITIS; ENTEROPATHY; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; ULCERATIVE COLITIS;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PHENOTYPE; YOUNG ADULT;

EID: 84865768344     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2012.02.006     Document Type: Article

References (24)

1. Kaser A., Zeissig S., Blumberg R.S. Inflammatory bowel disease. Annu Rev Immunol 2010, 28:573-621.
2. Podolsky D.K. Inflammatory bowel disease. N Engl J Med 2002, 347:417-429.
3. Cooney R., Jewell D. The genetic basis of inflammatory bowel disease. Dig Dis 2009, 27:428-442.
4. Wu F., Dassopoulos T., Cope L., Maitra A., Brant S.R., Harris M.L., et al. Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis. Inflamm Bowel Dis 2007, 13:807-821.
5. Budarf M.L., Labbé C., David G., Rioux J.D. GWA studies: rewriting the story of IBD. Trends Genet 2009, 25:137-146.
6. Costello C.M., Mah N., Häsler R., Rosenstiel P., Waetzig G.H., Hahn A., et al. Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays. PLoS Med 2005, 2:e199.
7. Shkoda A., Werner T., Daniel H., Gunckel M., Rogler G., Haller D. Differential protein expression profile in the intestinal epithelium from patients with inflammatory bowel disease. J Proteome Res 2007, 6:1114-1125.
8. Carthew R.W. Gene regulation by microRNAs. Curr Opin Genet Dev 2006, 16:203-208.
9. Archanioti P., Gazouli M., Theodoropoulos G., Vaiopoulou A., Nikiteas N. Micro-RNAs as regulators and possible diagnostic bio-markers in inflammatory bowel disease. Journal of Crohn's and Colitis 2011, 5:520-524.
10. Xiao C., Rajewsky K. MicroRNA control in the immune system: basic principles. Cell 2009, 136:26-36.
11. McKenna L.B., Schug J., Vourekas A., McKenna J.B., Bramswig N.C., Friedman J.R., et al. MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function. Gastroenterology 2010, 139:1654-1664.
12. Wu F., Zikusoka M., Trindade A., Dassopoulos T., Harris M.L., Bayless T.M., et al. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 2008, 135:1624-1635.
13. Wu F., Zhang S., Dassopoulos T., Harris M.L., Bayless T.M., Meltzer S.J., et al. Identification of microRNAs associated with ileal and colonic Crohn's disease. Inflamm Bowel Dis 2010, 16:1729-1738.
14. Wu F., Guo N.J., Tian H., Marohn M., Gearhart S., Bayless T.M., et al. Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 2011, 17:241-250.
15. Zahm A.M., Thayu M., Hand N.J., Horner A., Leonard M.B., Friedman J.R. Circulating MicroRNA is a biomarker of pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2011, 53:26-33.
16. Pekow J.R., Kwon J.H. MicroRNAs in inflammatory bowel disease. Inflamm Bowel Dis 2012, 18:187-193.
17. Dai Y., Huang Y.S., Tang M., Lv T.Y., Hu C.X., Tan Y.H., et al. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 2007, 16:939-946.
18. Fulci V., Scappucci G., Sebastiani G.D., Giannitti C., Franceschini D., Meloni F., et al. miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis. Hum Immunol 2010, 71:206-211.
19. Pauley K.M., Satoh M., Chan A.L., Bubb M.R., Reeves W.H., Chan E.K. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 2008, 10:R101.
20. Te J.L., Dozmorov I.M., Guthridge J.M., Nguyen K.L., Cavett J.W., Kelly J.A., et al. Identification of unique microRNA signature associated with lupus nephritis. PLoS One 2010, 5:e10344.
21. Tsujiura M., Ichikawa D., Komatsu S., Shiozaki A., Takeshita H., Kosuga T., et al. Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 2010, 102:1174-1179.
22. Carissimi C., Fulci V., Macino G. MicroRNAs: novel regulators of immunity. Autoimmun Rev 2009, 8:520-524.
23. Sonkoly E., Wei T., Janson P.C., Sääf A., Lundeberg L., Tengvall-Linder M., et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis?. PLoS One 2007, 2:e610.
24. Oertli M., Engler D.B., Kohler E., Koch M., Meyer T.F., Müller A. MicroRNA-155 is essential for the T cell-mediated control of helicobacter pylori infection and for the induction of chronic Gastritis and Colitis. J Immunol 2011, 187:3578-3586.